aiwiki.page
English
Health / Diseases & Symptoms / neural-tube-defect

Neural tube defect

A neural tube defect is a congenital malformation arising from abnormal early development of the brain, spinal cord, or their protective coverings.

42 keywords3 linked from10 not yet writtenWritten by AI
Neural TubeBrainSpinal CordPregnancyCentral Nervous…MeningesCerebrospinal Fl…BrainstemNeural tub…

A neural tube defect is a congenital malformation associated with abnormal formation or closure of the neural tube, the embryonic structure that gives rise to the brain and spinal cord. The principal forms are spina bifida, anencephaly, and encephalocele. Their effects range from localized spinal abnormalities with little functional impairment to extensive malformations incompatible with sustained survival. Most originate during the first month after fertilization, often before a pregnancy has been recognized.

Neural tube defects are important causes of fetal and infant death and lifelong neurological disability. Their occurrence reflects interactions among genetic susceptibility, maternal nutritional status, metabolic conditions, and some environmental exposures. Adequate periconceptional folic acid substantially reduces the occurrence of many, but not all, neural tube defects. Prenatal imaging, neonatal care, neurosurgical techniques, and multidisciplinary follow-up have changed their detection and clinical course. Understanding these conditions requires distinguishing the early developmental defect from the secondary injury and functional consequences that may evolve before and after birth.

Embryonic development and the origins of closure failure

The central nervous system begins as a thickened region of embryonic surface tissue called the neural plate. During primary neurulation, this plate elongates, bends, and forms paired neural folds that meet and fuse dorsally. The resulting tube separates from the overlying surface ectoderm, which subsequently forms skin. Its cranial portion develops into the brain, while its more caudal portion forms most of the spinal cord. Surrounding tissues contribute to the vertebral column, skull, and meninges, the membranes enclosing the nervous system.

In human development, closure begins during the third week after fertilization and proceeds through the fourth week. The cranial neuropore normally closes at approximately day 25 and the caudal neuropore around days 27–28, although developmental staging is more precise than assigning a single calendar day. These dates refer to age after fertilization; conventional obstetric gestational age, measured from the last menstrual period, is approximately two weeks greater. This distinction explains why the critical period is often described as occurring before the end of the sixth gestational week.

Closure is not simply the joining of two passive edges. It depends on coordinated cell proliferation, changes in cell shape, tissue bending, adhesion, and remodeling of the extracellular environment. Convergent extension narrows and lengthens the neural plate, helping bring its lateral margins together. Signaling pathways controlling planar cell polarity organize these cell movements across the tissue. Disruption of these processes can leave an open cranial or spinal region. Experimental models demonstrate that different disturbances can produce similar external malformations, so anatomical appearance does not identify a single underlying cause.

The lowest sacral and coccygeal regions develop partly through secondary neurulation, in which a solid cellular structure forms and subsequently develops a central cavity. Abnormalities involving this process can produce closed spinal malformations. Consequently, the broader clinical category of spinal dysraphism includes conditions whose developmental origins differ from classic failure of primary neural tube closure.

In open defects, the initial malformation is followed by additional damage. Exposed neural tissue may undergo degeneration through contact with amniotic fluid and mechanical injury. In cranial defects, initially formed but exposed brain tissue can progressively deteriorate. In open spinal defects, loss of protective coverings and altered cerebrospinal fluid dynamics contribute to subsequent abnormalities. This distinction between an initial developmental event and later injury provides part of the biological rationale for prenatal surgical closure in selected cases.

Major anatomical forms and classification

Spina bifida encompasses a spectrum of spinal malformations involving incomplete formation of posterior vertebral structures, sometimes accompanied by abnormalities of the spinal cord and its coverings. The most clinically important open form is myelomeningocele, in which neural tissue and meninges are exposed or protrude through a vertebral defect. Lesions most often involve the lower spine, although they can occur at other levels. Myeloschisis describes an open, relatively flat neural plate without a well-formed covering sac. These defects are generally grouped as open spinal dysraphism.

A meningocele is a protruding sac containing meninges and cerebrospinal fluid without substantial spinal cord tissue within the sac. Its neurological effects can be less severe than those of myelomeningocele, but associated abnormalities remain important. Closed spinal dysraphism includes lesions covered by skin, such as lipomyelomeningocele and some forms of split cord malformation or dermal sinus. Simple spina bifida occulta, often identified incidentally as nonfusion of a vertebral arch, is not equivalent to an open neural tube defect and may have no clinical consequences. Classification systems differ in whether and how they include these closed abnormalities.

Anencephaly results from failure of normal cranial neural tube development, with absence of major portions of the brain and cranial vault. It is not the complete absence of every brain structure: portions of the brainstem and other neural tissue may remain. Anencephaly is incompatible with sustained survival, and affected pregnancies frequently end in fetal death or death shortly after birth. Acrania and exencephaly describe related developmental appearances involving absence of the cranial vault and exposed abnormal brain tissue; degeneration of exposed tissue can produce the later anencephalic appearance.

Encephalocele is herniation of intracranial contents through a skull defect. A sac may contain meninges and cerebrospinal fluid alone or also contain brain tissue. Occipital lesions occur at the back of the head, whereas frontoethmoidal lesions involve the region between the forehead and nose. Outcome depends on the location, the amount and type of herniated neural tissue, associated brain abnormalities, and whether a broader syndrome is present. Encephaloceles are conventionally included among neural tube defects in many surveillance systems, although their developmental mechanisms are not always identical to those of open closure defects.

Craniorachischisis is a severe malformation combining an open cranial defect with a continuous open spinal defect. Iniencephaly is characterized by marked backward bending of the head and abnormalities of the occiput and cervical spine. These uncommon forms illustrate why neural tube defects cannot be treated as a single uniform anatomical condition. Reliable comparison of clinical studies requires explicit definitions of the lesions included.

Genetic susceptibility and maternal risk factors

Most nonsyndromic neural tube defects have a multifactorial origin rather than a simple dominant or recessive inheritance pattern. Multiple genetic variants can influence susceptibility, while nutrition and maternal exposures affect whether development crosses a threshold for malformation. A previous affected pregnancy increases the probability of another affected pregnancy. Recurrence estimates vary among populations and clinical circumstances, but after one affected pregnancy a risk of roughly 2–3% has often been reported in the absence of preventive measures. This is higher than the population risk without implying that recurrence is inevitable.

Genes involved in planar cell polarity, folate handling, and other developmental pathways have been implicated. Rare variants affecting proteins such as VANGL1 and VANGL2 have been identified in some affected individuals or families, but these findings explain only a minority of cases. Common variants in the MTHFR gene, particularly C677T, have associations that depend partly on population background and nutritional status. Such variants are neither necessary nor sufficient to cause a neural tube defect and do not provide a stand-alone diagnostic explanation for most cases.

Some neural tube defects occur within chromosomal disorders or recognizable genetic syndromes. Encephalocele, for example, can be part of Meckel–Gruber syndrome, a recessively inherited disorder commonly associated with cystic kidneys and extra digits. Trisomy 13 and trisomy 18 can also include neural tube or related central nervous system malformations. The presence of additional structural abnormalities changes the likelihood of an underlying chromosomal or single-gene condition and is relevant to genetic counseling.

Maternal diabetes mellitus predating pregnancy is an established risk factor, particularly when blood glucose is elevated during early organ formation. Maternal obesity is also associated with increased risk, although the mechanisms are incompletely resolved and may include metabolic and nutritional factors. Some antiseizure medicines, especially valproate, increase the risk of neural tube defects following exposure during early pregnancy. Other medicines that interfere with folate metabolism have also been associated with developmental risk. Drug-specific effects cannot be inferred simply from membership in a broad medication class.

Elevated maternal core temperature during the critical developmental period, including that associated with significant fever, has been linked to increased risk. Evidence for many occupational chemicals, pollutants, and dietary exposures is less consistent and is difficult to separate from confounding factors. Low folate status is a major modifiable contributor, but a defect in an individual pregnancy cannot usually be attributed to one exposure. The persistence of cases despite adequate folic acid intake demonstrates that folate-sensitive and folate-resistant developmental pathways both exist.

Distribution, burden, and surveillance

Neural tube defects occur worldwide, but recorded frequency varies considerably across regions, periods, and population groups. Reported birth prevalence ranges from a few cases to several tens of cases per 10,000 births. Differences reflect folate intake, food fortification, genetic background, maternal health, and access to diagnostic services. Historical studies have documented particularly high rates in some regions, including parts of northern China and the British Isles, while subsequent nutritional and public-health changes have altered these patterns.

The choice of denominator is crucial in epidemiology. Birth prevalence may count affected live births and stillbirths per total births, whereas total prevalence in congenital anomaly surveillance may also include pregnancies terminated following prenatal diagnosis. Neither directly measures the number of affected conceptions, because early spontaneous losses are incompletely observed. Studies using only live-birth records substantially underestimate anencephaly and other severe defects when fetal deaths and prenatal diagnoses are common.

Prenatal detection introduces an additional interpretive issue. A decline in the number of infants born with a neural tube defect may reflect a reduction in occurrence, changes in pregnancy outcomes after diagnosis, or both. Evaluation of primary prevention therefore requires surveillance that captures the widest feasible range of pregnancy outcomes and maintains stable case definitions. Changes in access to imaging, recording practices, and legislation can affect measured trends independently of changes in embryonic development.

The International Classification of Diseases provides categories for recording anencephaly and similar malformations, encephalocele, and spina bifida. In ICD-10 these are principally Q00, Q01, and Q05. Administrative codes are useful for large-scale analysis but can misclassify lesion type or include conditions outside a study’s intended definition. Specialist registries often supplement codes with imaging findings, clinical descriptions, and expert review. Isolated vertebral arch defects, in particular, must be distinguished from clinically significant spinal dysraphism.

The burden extends beyond early mortality. Survivors with spinal lesions may require repeated operations, management of urinary and bowel dysfunction, mobility equipment, educational support, and care extending throughout adult life. Measures such as disability-adjusted life years capture some of this burden but do not fully describe individual participation or family experience. Geographic comparisons also reflect differences in neonatal survival and access to treatment. A population with better survival may have more adults living with spina bifida even when the frequency of affected pregnancies is lower.

Folate biology and population prevention

Folate is a B vitamin required for one-carbon metabolism, including synthesis of nucleotide building blocks and reactions involved in methylation. Rapidly dividing embryonic tissues depend on these processes. Folic acid is the synthetic form commonly used in supplements and food fortification. Although its preventive effect is well established, the precise sequence connecting folate availability to successful neural tube closure is not fully resolved. Effects on nucleotide supply, cell proliferation, and regulation of gene expression are among the mechanisms under investigation.

A major landmark was the Medical Research Council Vitamin Study, published in 1991. This randomized controlled trial enrolled women with a previous neural tube defect–affected pregnancy and found that periconceptional folic acid reduced recurrence by approximately 72%. The trial used 4 mg daily. A Hungarian randomized trial published in 1992 demonstrated prevention of first occurrence with a multivitamin preparation containing 0.8 mg of folic acid. Because that preparation contained several vitamins, its findings are interpreted alongside other evidence rather than as an isolated estimate of folic acid’s effect.

Timing is central to prevention. Neural tube closure is largely complete before many pregnancies are recognized, so supplementation begun only after a routine first antenatal appointment may miss the relevant developmental window. Public-health recommendations therefore commonly describe folic acid intake before conception and during early pregnancy. For people who could become pregnant, many national recommendations use 400 micrograms daily; some guidelines specify a range of 400–800 micrograms. Higher-dose regimens appear in guidelines for selected high-risk circumstances, with doses and eligibility varying by jurisdiction.

Mandatory fortification extends prevention beyond those using supplements before conception. The United States required folic acid fortification of enriched cereal grain products beginning in 1998, at 140 micrograms per 100 grams of product. Canada introduced a similar program in the same period, and numerous other countries subsequently adopted fortification policies. Surveillance studies have documented substantial reductions in neural tube defects after implementation, although the size of the reduction depends on baseline nutritional status, foods covered, consumption patterns, and ascertainment methods.

Fortification does not prevent every case, and its reach depends on which staple foods are included. Populations relying mainly on foods outside the fortification program may receive less benefit. Program evaluation therefore combines food-content monitoring, dietary data, folate measurements, and congenital anomaly surveillance. Vitamin B12 status is also relevant to one-carbon metabolism and to the interpretation of some folate-related laboratory findings. The residual burden after folic acid interventions remains an important focus of developmental and nutritional research.

Prenatal screening and diagnostic assessment

Prenatal detection relies primarily on ultrasonography, supported in some settings by maternal serum testing. Anencephaly can often be recognized during first-trimester imaging because the cranial vault is absent and brain development is markedly abnormal. Many spinal defects are identified during the detailed mid-trimester anatomical examination, commonly performed at approximately 18–22 weeks of gestation. Detection depends on lesion type, fetal position, image quality, gestational age, and examiner experience. Small or skin-covered spinal abnormalities are more difficult to identify than large open lesions.

Ultrasound assessment of suspected open spina bifida includes the spine, overlying tissues, lower-limb movement, and intracranial anatomy. The “lemon sign” describes inward scalloping of the frontal bones, while the “banana sign” describes an altered cerebellar shape associated with downward displacement of hindbrain structures. These are indirect findings rather than separate defects. Ventricular enlargement and abnormalities of the posterior fossa may also be present. A detailed examination looks for additional malformations that could indicate a chromosomal or syndromic condition.

Alpha-fetoprotein is produced mainly by the fetal liver and yolk sac. Open fetal defects can allow increased quantities to enter amniotic fluid and the maternal circulation. Maternal serum alpha-fetoprotein testing, generally performed during the second trimester, can therefore indicate increased probability of an open neural tube defect. Results are usually expressed as multiples of the median for gestational age. Interpretation accounts for factors such as dating, number of fetuses, and maternal characteristics. Elevated levels are not specific to neural tube defects and can occur with abdominal wall defects and other pregnancy conditions.

Historically, amniocentesis with measurement of amniotic-fluid alpha-fetoprotein and acetylcholinesterase played a prominent confirmatory role. High-quality ultrasound has reduced the need for invasive biochemical confirmation in many settings, although invasive testing may still be performed for genetic evaluation or unresolved findings. Standard cell-free DNA screening for common chromosomal aneuploidies does not screen reliably for neural tube defects. A negative result from that test therefore does not exclude a structural neural tube abnormality.

Fetal magnetic resonance imaging can complement ultrasound when additional detail about the brain, spinal cord, or an encephalocele is needed. It is not a replacement for the initial anatomical survey. Diagnostic assessment also distinguishes open dysraphism from sacrococcygeal tumors, cystic lesions, and other spinal masses. The information obtained supports description of the lesion, evaluation of associated abnormalities, and discussion of the range of possible outcomes. Prenatal imaging cannot predict every aspect of later mobility, continence, learning, or independence.

Neurological and systemic consequences

The effects of spinal neural tube defects depend strongly on the functional level and extent of neural injury. A higher spinal lesion generally affects more muscle groups and produces greater impairment of lower-limb movement and sensation. Anatomical vertebral level and functional neurological level do not always coincide, however. Some children with low lesions walk independently, while others use orthoses, walking aids, wheelchairs, or a combination that changes with age. Reduced sensation increases the risk of unnoticed skin injury, pressure damage, and burns.

Open myelomeningocele is commonly associated with Chiari II malformation, a complex developmental abnormality involving a small posterior fossa and downward displacement of hindbrain structures. It can affect the cerebellum, brainstem, and cerebrospinal fluid pathways. Symptoms may include swallowing difficulties, disordered breathing, or weakness affecting upper structures, although imaging findings do not necessarily correspond to clinical severity. Hydrocephalus, an abnormal accumulation of cerebrospinal fluid with ventricular enlargement, is another frequent associated condition and may require diversion or other neurosurgical treatment.

Bladder dysfunction results from disturbed communication among the brain, spinal cord, and lower urinary tract. The bladder may store urine at abnormally high pressure, empty incompletely, or exhibit poorly coordinated contraction and outlet relaxation. These patterns can cause incontinence and recurrent urinary tract infections, but continence alone does not indicate whether bladder pressures are safe. Persistent high-pressure storage and urinary reflux can damage the kidneys. Neurogenic bowel dysfunction can produce constipation, incomplete evacuation, and fecal incontinence.

Musculoskeletal effects include congenital foot deformities, hip abnormalities, joint contractures, and scoliosis. Weakness and altered loading influence bone growth and alignment. Reduced weight-bearing can contribute to low bone density and fractures, which may produce few typical symptoms when sensation is impaired. Growth, weight changes, and increasing physical demands can alter mobility even without a new neurological lesion. Skin breakdown can likewise reduce function and interrupt schooling, work, or rehabilitation.

The spinal cord may become abnormally attached to surrounding tissues, producing tethering. Anatomical tethering after myelomeningocele closure is common, but tethered cord syndrome refers to clinical deterioration associated with traction, such as worsening gait, pain, new weakness, or changes in bladder function. Some individuals also have differences in attention, executive function, visual-spatial skills, or mathematics, particularly when hydrocephalus and associated brain abnormalities are present. Intellectual disability is not an inevitable consequence of spina bifida, and cognitive profiles vary widely.

Surgical treatment and multidisciplinary care

Postnatal treatment of open myelomeningocele begins with protecting the exposed tissue and assessing neurological status, associated abnormalities, and infection risk. Surgical closure is generally undertaken early after birth, often within the first 24–48 hours when circumstances permit. The operation reconstructs protective tissue layers and covers the defect; it cannot restore neural tissue that failed to form or has already been damaged. Encephalocele surgery likewise depends on the sac’s contents, skin coverage, venous anatomy, associated abnormalities, and the feasibility of reconstruction.

Hydrocephalus is commonly treated with a ventriculoperitoneal shunt, which diverts cerebrospinal fluid from the ventricles to the abdominal cavity. Shunts can become obstructed or infected and may require revision. Endoscopic third ventriculostomy, sometimes combined with choroid plexus cauterization, is an alternative in selected patients, but success depends on age, anatomy, and the cause of hydrocephalus. Not every enlarged ventricle requires an operation; clinical progression and the overall assessment of cerebrospinal fluid dynamics are important.

Prenatal repair aims to limit ongoing injury to exposed spinal tissue and improve cerebrospinal fluid relationships before birth. The Management of Myelomeningocele Study, a randomized trial published in 2011, compared prenatal open repair with standard postnatal repair in carefully selected pregnancies. The trial was stopped early for benefit after enrolling 183 participants. Shunt placement by 12 months occurred in approximately 40% of the prenatal-surgery group and 82% of the postnatal-surgery group; selected motor outcomes also favored prenatal repair. These results did not establish a cure or apply automatically to every fetus with spina bifida.

Prenatal surgery introduces maternal and pregnancy risks, including membrane complications, preterm birth, and consequences of the uterine incision for the current and later pregnancies. Open and fetoscopic approaches differ technically and have different complication profiles. Comparative evidence continues to develop, especially for longer-term function and maternal outcomes. Fetal surgery is therefore characterized by strict selection criteria, specialist teams, and assessment of both maternal and fetal outcomes rather than by the spinal lesion alone.

Long-term care commonly combines neurosurgery, urology, orthopedics, developmental care, and rehabilitation. Bladder management may involve intermittent catheterization, medicines, surveillance of urinary tract function, and selected reconstructive procedures. Bowel programs use individualized combinations of dietary measures, medicines, irrigation, or surgery. Physical therapy, occupational therapy, orthoses, and mobility equipment address function and participation. Treatment priorities differ by age and phenotype, and the outcomes of spinal lesions should not be generalized to lethal cranial defects such as anencephaly, for which care has a different purpose.

Survival, adult life, and continuing research

Survival with spina bifida improved markedly during the twentieth century as neonatal closure, cerebrospinal fluid shunting, infection treatment, and protection of kidney function became more widely available. Many affected individuals now reach adulthood, and some live into later adult life. Outcomes remain heterogeneous and depend on lesion severity, associated brain abnormalities, renal health, respiratory problems, and continuity of care. Historical survival figures cannot be applied directly to contemporary children because the clinical population and available treatments have changed.

Adult care involves more than persistence of childhood treatment. Shunt complications can occur many years after placement, and changes in strength, gait, continence, or cognition can signal new problems. Chronic pain, musculoskeletal strain, skin injury, and metabolic conditions can become increasingly important. Sexual function, fertility, pregnancy, and reproductive genetics are also relevant aspects of adult medicine. The transition from pediatric to adult services is a recognized point at which access to specialist knowledge and coordinated follow-up may become fragmented.

Health-related quality of life is not determined by walking status alone. Continence, pain, social inclusion, accessible housing, education, employment, and control over daily activities all influence participation. Wheelchairs and other assistive technologies can expand mobility rather than simply indicate loss of function. Studies that measure only anatomical impairment or numbers of operations miss these dimensions. Patient-reported outcomes add information about priorities and experiences that clinical examinations do not capture.

Research on prevention seeks to explain why some defects respond to folic acid and others do not. Animal models allow detailed study of neural fold mechanics, cell polarity, tissue metabolism, and interactions between genetic variants and maternal conditions. Human genomic studies face the challenge that neural tube defects are uncommon, anatomically diverse, and influenced by many factors. Pooling different lesion types can increase sample size while obscuring distinct developmental mechanisms. Identification of an associated genetic variant also does not by itself establish a useful screening test.

Clinical research is extending follow-up after prenatal repair to school-age and adult outcomes, including mobility, bladder and bowel function, cognition, and maternal reproductive health. Other studies examine ways to reduce shunt dependence, improve urinary tract protection, and prevent secondary tissue injury. Experimental regenerative approaches remain distinct from established treatment. Across these fields, meaningful comparison requires consistent lesion definitions, documentation of associated abnormalities, and outcome measures that include both medical complications and everyday function.